Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v8-EN | Version v7-EN | |
---|---|---|
Language | English | English |
Date Updated | 2024-09-23 | 2024-09-21 |
Drug Identification Number | 02362597 | 02362597 |
Brand name | POTASSIUM ACETATE INJECTION USP | POTASSIUM ACETATE INJECTION USP |
Common or Proper name | POTASSIUM ACETATE INJECTION | POTASSIUM ACETATE INJECTION |
Company Name | OMEGA LABORATORIES LIMITED | OMEGA LABORATORIES LIMITED |
Ingredients | POTASSIUM ACETATE | POTASSIUM ACETATE |
Strength(s) | 39.2% | 39.2% |
Dosage form(s) | LIQUID | LIQUID |
Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
Packaging size | 10 x 50mL vial / fiole | 10 x 50mL vial / fiole |
ATC code | B05XA | B05XA |
ATC description | I.V. SOLUTION ADDITIVES | I.V. SOLUTION ADDITIVES |
Reason for shortage | Shortage of an active ingredient. | Shortage of an active ingredient. |
Anticipated start date | 2024-09-13 | 2024-09-13 |
Actual start date | 2024-09-20 | 2024-09-20 |
Estimated end date | 2025-01-06 | 2025-01-06 |
Actual end date | ||
Shortage status | Actual shortage | Actual shortage |
Tier 3 Status | No | No |
Company comments | Some product remains available at Omega. Sodium Acetate, which can be used as a substitute for Potassium Acetate, is also available at CPDN and Omega. | The product remains available at CPDN Delta and Omega. Sodium Acetate, which can be used as a substitute for Potassium Acetate, is also available at CPDN and Omega. |
Health Canada comments |